Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 3 Prostatic Neoplasms 1 Polyps 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 NSCLC 1 Multiple Myeloma 1 Mouth Neoplasms 1 Breast Neoplasms 1 Aggressive Periodontitis 1 Adenomatous Polyps 1 Adenoma 1

Interventions

Pemetrexed 2 Gefitinib 2 spartalizumab 1 aflutinib 1 Tyrosine Kinase Inhibitors 1 Thalidomide 1 Radiosurgery 1 Platinum 1 Immune Checkpoint Inhibitors 1 Drug Therapy 1 Axitinib 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × NSCLC × Aspirin × Clear all

NCT02387086 2015-03-12

Gefitinib Combined With Thalidomide to Treat NSCLC

Shaanxi Provincial People's Hospital

Phase 2/3 Unknown

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡